small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search

Capabilities 71 results

Industry

Sports

Winston has one of the world’s premier sports law practices. Our work has included some of the most famous legal matters in sports history—including Alston v. NCAA, the case that culminated in a 9–0 Supreme Court victory for the college players against the NCAA; the US$2.15B Los Angeles Dodgers acquisition; McNeil v. the NFL, the landmark antitrust jury trial that led to the establishment of free agency in the NFL; the multi-billion-dollar construction and permanent financings for SoFi Stadium; and Morgan v. USSF, the case that led to a historic equal pay settlement for the players on the Women’s National Team. Our work is transforming this global, multibillion-dollar industry....Read more

Practice Area

Fund Finance

We advise clients that originate, manage, and invest in broadly syndicated and middle-market corporate loans with their fund formation and capital markets fund-financing activities. Our experience includes structure and formation of CLOs, registered funds, hedge funds, listed funds, private credit funds, managed accounts, synthetic funds, SBICs, and onshore and offshore special purpose investment vehicles. Our experience spans the complete spectrum of services, including warehouse, leverage, and subscription facilities and ongoing portfolio support. Our Capital Markets Practice has extensive experience in debt and equity offerings, spin-offs, split-offs, and carve-outs, as well as securities compliance and corporate governance....Read more

Practice Area

Public Companies

Winston offers a comprehensive cross-practice area Public Company Advisory Group, which leverages the collective experience of our Capital Markets and Securities, M&A, Employee Benefits & Executive Compensation, Intellectual Property, Labor & Employment, Complex Commercial and Securities Litigation, and Tax practices, to advise our clients on the wide range of issues they face as public companies. With extensive experience providing top-tier legal counsel to our clients, we have cultivated a deep reservoir of knowledge in SEC reporting and compliance, capital markets, executive compensation, and corporate governance matters, earning the trust of numerous public company clients as their legal advisors in these critical areas....Read more

Insights & News 2,058 results

Article

|

May 5, 2025

|

9 Min Read

A Look At AI Benefits And Risks In Global Development Efforts

This article was originally published in Law360. Any opinions in this article are not those of Winston & Strawn or its clients. The opinions in this article are the authors’ opinions only....Read more

Competition Corner

|

May 2, 2025

|

4 Min Read

Washington State Enacts a Broad Premerger Notification Requirement for All Industries

Washington recently became the first state to adopt the Uniform Antitrust Premerger Notification Act (UAPNA) and establish, effective July 27, 2025, a general state-level premerger notification requirement for all transactions. 

Client Alert

|

May 2, 2025

|

4 Min Read

White House Memorandum Elaborates on Prior Executive Order with Requirements for “High-Impact AI” Used by Federal Agencies

On April 3, 2025, the Office of Management and Budget issued a memorandum expounding upon the January 23, 2025 Executive Order (EO) 14179, Removing Barriers to American Leadership in Artificial Intelligence, to put forth new requirements for the implementation of Artificial Intelligence (AI) in U.S. federal agencies, with specific requirements where the AI use is considered “high impact.” 

View All Insights & News

Other Results 48 results

Site Content

Associate Salary Disclosures

Law Glossary

What Exclusivity Periods Are Associated with Biosimilars?

An applicant may not submit an aBLA until four years after the reference product is licensed by the FDA. (See BPCIA § 351(k).) Further, any biosimilar licenses “may not be made effective” until 12 years after the reference product was licensed. (See BPCIA § 351(l).)...Read more

Experienced Attorneys

Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising